NORTHAMPTON, MA / ACCESS Newswire / April 29, 2025 / Gilead is committed to using its virology expertise to advance HIV ...

ViiV leads the 2024/25 pharma company reputation rankings, with the PatientView report also finding ways in which the ...

The S&P 500 edged 0.1% higher on Monday, April 28, eking out a fifth straight winning session to kick off a week of key ...

Gilead Sciences Inc is a biopharmaceutical company that discovers, develops and commercializes new medicines in areas of unmet medical need. Its products target a number of areas, such as HIV, liver ...

Gilead Sciences, Inc. today announced new research to be presented at the European Association for the Study of the Liver (EASL) Congress, May 7-10, 2025, Amsterdam, furthering Gilead's commitment to ...

Sexual health is gaining recognition as a crucial aspect of comprehensive health and wellness, especially as evidence mounts on the adverse long-term ...